113 related articles for article (PubMed ID: 1830752)
1. Pharmacologic antagonism of thromboxane A2 receptors by trimetoquinol analogs in vitro and in vivo.
Shin Y; Romstedt KJ; Doyle K; Harrold MW; Gerhardt MA; Miller DD; Patil PN; Feller DR
Chirality; 1991; 3(2):112-7. PubMed ID: 1830752
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade.
Ahn CH; Romstedt KJ; Wallace LJ; Miller DD; Feller DR
Biochem Pharmacol; 1988 Aug; 37(15):3023-33. PubMed ID: 3134894
[TBL] [Abstract][Full Text] [Related]
3. Halogen-substituted trimetoquinol analogs as thromboxane A2 receptor antagonists in platelets and aorta.
Romstedt KJ; Shin Y; Shams G; Doyle K; Tantishaiyakul V; Clark MT; Adejare A; Hamada A; Miller DD; Feller DR
Biochem Pharmacol; 1993 Dec; 46(11):2051-9. PubMed ID: 8267653
[TBL] [Abstract][Full Text] [Related]
4. Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta.
Mukhopadhyay A; Navran SS; Amin HM; Abdel-Aziz SA; Chang J; Sober DJ; Miller DD; Feller DR
J Pharmacol Exp Ther; 1985 Jan; 232(1):1-9. PubMed ID: 3855323
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological evaluation of the beta-adrenoceptor agonist and thromboxane receptor blocking properties of 1-benzyl substituted trimetoquinol analogues.
Shams G; Romstedt KJ; Gerhardt MA; Harrold MW; Miller DD; Feller DR
Eur J Pharmacol; 1990 Aug; 184(1):21-31. PubMed ID: 1976530
[TBL] [Abstract][Full Text] [Related]
6. Interactions of nonprostanoid trimetoquinol analogs with thromboxane A2/prostaglandin H2 receptors in human platelets, rat vascular endothelial cells and rat vascular smooth muscle cells.
Shin Y; Romstedt KJ; Miller DD; Feller DR
J Pharmacol Exp Ther; 1993 Dec; 267(3):1017-23. PubMed ID: 7903383
[TBL] [Abstract][Full Text] [Related]
7. Use of [3H]trimetoquinol as a radioligand in human platelets: interaction with putative endoperoxide/thromboxane A2 receptor sites.
Ahn CH; Wallace LJ; Miller DD; Feller DR
Thromb Res; 1988 May; 50(3):387-99. PubMed ID: 2969151
[TBL] [Abstract][Full Text] [Related]
8. Effects of thromboxane A2 on thoracic aorta of young and old rats: use of selective thromboxane receptor antagonists.
Shams G; Wallace LJ; Miller DD; Feller DR
Pharmacology; 1990; 40(1):27-32. PubMed ID: 2139513
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and platelet antiaggregatory activity of trimetoquinol analogs as endoperoxide/thromboxane A2 antagonists.
Harrold MW; Gerhardt MA; Romstedt K; Feller DR; Miller DD
Drug Des Deliv; 1987 Feb; 1(3):193-207. PubMed ID: 3509333
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of halogenated trimetoquinol derivatives and evaluation of their beta-agonist and thromboxane A2 (TXA2) antagonist activities.
Markovich KM; Tantishaiyakul V; Hamada A; Miller DD; Romstedt KJ; Shams G; Shin Y; Fraundorfer PF; Doyle K; Feller DR
J Med Chem; 1992 Feb; 35(3):466-79. PubMed ID: 1346651
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological evaluation of the beta-adrenoceptor agonist and thromboxane antagonist properties of N-substituted trimetoquinol analogues.
Fedyna JS; Adejare A; Miller DD; Feller DR
Eur J Pharmacol; 1987 Mar; 135(2):161-71. PubMed ID: 2884118
[TBL] [Abstract][Full Text] [Related]
12. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
[TBL] [Abstract][Full Text] [Related]
13. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
Mais DE; Burch RM; Saussy DL; Kochel PJ; Halushka PV
J Pharmacol Exp Ther; 1985 Dec; 235(3):729-34. PubMed ID: 3001275
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.
Harris DN; Michel IM; Goldenberg HJ; Hartl KS; Allen GT; Steinbacher TE; Schumacher WA; Han WC; Hall SE; Floyd DM
J Pharmacol Exp Ther; 1992 Apr; 261(1):131-7. PubMed ID: 1532833
[TBL] [Abstract][Full Text] [Related]
15. Desensitization of platelet thromboxane A2/prostaglandin H2 receptors by the mimetic U46619.
Liel N; Mais DE; Halushka PV
J Pharmacol Exp Ther; 1988 Dec; 247(3):1133-8. PubMed ID: 2974487
[TBL] [Abstract][Full Text] [Related]
16. Agents combining thromboxane receptor antagonism with thromboxane synthase inhibition: [[[2-(1H-imidazol-1-yl)ethylidene]amino]oxy]alkanoic acids.
Cozzi P; Giordani A; Menichincheri M; Pillan A; Pinciroli V; Rossi A; Tonani R; Volpi D; Tamburin M; Ferrario R
J Med Chem; 1994 Oct; 37(21):3588-604. PubMed ID: 7932586
[TBL] [Abstract][Full Text] [Related]
17. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation.
Furci L; Fitzgerald DJ; Fitzgerald GA
J Pharmacol Exp Ther; 1991 Jul; 258(1):74-81. PubMed ID: 1830100
[TBL] [Abstract][Full Text] [Related]
19. Beta-adrenergic receptor and platelet inhibitory activities of a new series of trimetoquinol and related benzazepine analogs.
Shams G; Romstedt KJ; Lust LA; Clark MT; Miller DD; Feller DR
Gen Pharmacol; 1997 Feb; 28(2):323-30. PubMed ID: 9013212
[TBL] [Abstract][Full Text] [Related]
20. Stereo-dependent inhibition of human platelet function by the optical isomers of trimetoquinol.
Mayo JR; Navran SS; Huzoor-Akbar ; Miller DD; Feller DR
Biochem Pharmacol; 1981 Aug; 30(16):2237-41. PubMed ID: 7188564
[No Abstract] [Full Text] [Related]
[Next] [New Search]